Group Overview 2 A Purpose-Led Approach 4 Navigating This Report 5 Investment Case 6 Clinical Excellence 10 IHH at a Glance 12 Financial Highlights 14 Operational and Sustainability Highlights 16 Corporate Milestones 2023 18 Awards and Accreditations Strategic Report 22 Chairman’s Statement 26 Group CEO’s Message 30 Business Strategy 32 Business Model 34 Impact of Value Creation 36 Operations Review 36 Malaysia 37 Singapore 38 Türkiye and Europe 39 India 40 Greater China 41 Parkway Life REIT 41 Laboratories 42 Financial Review 44 Market Outlook 48 Stakeholder Engagement 52 Our Material Matters 55 Risk Management 56 Principal Risks Sustainability 61 Sustainability Opening Statement 62 Sustainability Approach 64 Sustainability Highlights 65 Sustainability Goals 66 Sustainability Snapshots 68 Sustainability Governance Governance 71 Board of Directors 78 Group Management 84 Corporate Governance Overview Statement 101 Nomination and Remuneration Committee Report 106 Audit Committee Report 109 Risk Management Committee Report 111 Statement on Risk Management and Internal Control 119 Investor Relations Report Other Information 122 Additional Compliance Information 124 Directors’ Responsibility Statement Financial Statements 126 Directors’ Report 132 Statement by Directors 133 Statutory Declaration 134 Independent Auditors’ Report 137 Statements of Financial Position 139 Statements of Profit or Loss and Other Comprehensive Income 140 Statements of Changes in Equity 146 Statements of Cash Flows 148 Notes to the Financial Statements Additional Corporate Information 249 Analysis of Shareholdings 251 List of Top 30 Largest Shareholders 253 List of Top 10 Properties 255 Notice of Fourteenth Annual General Meeting Form of Proxy Annual Report 2023 1 Content
RkJQdWJsaXNoZXIy NDgzMzc=